Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Fulgent Genetics reported a net loss of $13.2 million for Q3 2026 on revenue of $90.4 million, compared to a net loss of $6.6 million on $84.1 million in revenue for the same period in 2025. The company's cash and marketable securities position decreased significantly from $636.0 million at year-end 2025 to $652.3 million as of September 30, 2026, impacted by $64.6 million in common stock repurchases during the first nine months of the year.
Bentley Systems reported total revenues of $421.5 million for the third quarter of 2026, a 12.2% increase compared to the same period in 2025, driven primarily by subscription growth. Net income attributable to the company rose significantly to $89.9 million, up from $57.4 million in the prior year, reflecting improved operating margins and higher income from operations.
For the nine months ended September 30, 2026, BRC Group Holdings, Inc. reported total revenues of $624.2 million and a net loss of $3.9 million, a significant decline from the $220.0 million net income in the prior year period. The company's balance sheet shows a total deficit of $44.6 million, though this improved from a $120.3 million deficit at the end of 2025.
Inogen appointed current COO Andy Reding as President and CEO and a member of the Board of Directors, effective October 30, 2026. He succeeds Kevin R.M. Smith, whose role as an officer and employee ended on the same date. The transition occurs as the company focuses on a more streamlined commercial model following the divestiture of its U.S. rental business.
indie Semiconductor reported Q3 2026 revenue of $70.2 million, representing 31% year-over-year growth and exceeding the midpoint of its previous outlook. The company narrowed its non-GAAP operating loss to $7.2 million and highlighted a major radar chipset design win with a top-three North American OEM.
Term
Q3 2026
“We reported strong third quarter results, with revenue up 31 percent year-over-year, ahead of our outlook, and our non-GAAP operating loss narrowed by more than a third. Our radar chipset, in high-volume production, has been selected by one of the top three North American OEMs, our sensing and perception portfolio is expanding rapidly into Physical AI, and with our fourth quarter outlook implying approximately 33 percent year-over-year growth, indie is very well positioned for the future.”
Donald McClymont, indie’s co-founder and chief executive officer
Mustang Bio, Inc. reported a net loss of $3.0 million for the nine months ended September 30, 2026, compared to $1.4 million in the prior year period. As of September 30, 2026, the company maintained $14.3 million in cash and cash equivalents and an accumulated deficit of $401.6 million, noting that additional capital will be required to fund future operations.
FIGS, Inc. reported third quarter 2026 financial results with net revenues increasing 25.7% year-over-year to $190.7 million, driven by strong growth in both scrubwear and international markets. The company achieved a net income of $19.3 million and raised its full-year 2026 revenue growth outlook to approximately 23.5%.
Term
Q3 2026
“Our momentum continued in Q3, which marked our fourth straight quarter of greater than 25% net revenues growth, powered by consistent strength across our categories, channels and geographies. This inflection in our business reflects the combined power of great product, marketing campaigns that resonate deeply, a passionate community and strong industry fundamentals.”
Trina Spear, Chief Executive Officer and Co-Founder
“We performed at a high level in Q3, delivering better-than-expected overall results. Net revenues grew 26%, highlighted by accelerations in active customer growth to 14.3%, average order value growth to 10.5%, and net revenues per active customer, which grew to a record $236.”
HA Sustainable Infrastructure Capital (HASI) reported third quarter 2026 financial results with GAAP EPS of $1.04 and Adjusted EPS of $0.82. The company's managed assets grew 27% year-over-year to $19.0 billion, and management reaffirmed its 2028 guidance for Adjusted EPS and ROE.
Term
Q3 2026
“Our team continues to execute on our business plan by adding new clients and deepening our relationships with existing ones, further diversifying into new asset classes, and optimizing our capital platform. These factors have translated into superb financial results through the first three quarters of 2026 with our Managed Assets increasing nearly $3 billion to $19 billion, Adjusted Recurring Net Investment Income growing 23% and Adjusted EPS by 15% year-to-date, and our Adjusted ROE rising to 15.6%.”
Jeffrey A. Lipson, President and Chief Executive Officer
“As much of the global economy has been adjusting to the increase in interest rates over the last few months, HASI continues to demonstrate the benefits of our business model in mitigating the impacts of a higher interest rate environment. Our new asset yields have increased to more than 11% year-to-date and we have continued to maintain our net investment margins. In combination with our growing base of management fees, we are generating greater profitability that is increasingly resilient to changes in the interest rate environment.”
For the nine months ended September 30, 2026, Sempra reported net income of $3,206 million, a significant increase from $1,588 million in 2025, driven by higher equity earnings and a gain on sales. Total revenues remained relatively stable at $9,843 million, while the company continued heavy capital investment with $7,327 million in property, plant, and equipment expenditures.
Teradata reported third quarter 2026 financial results with total revenue of $399 million and non-GAAP diluted EPS of $0.70. The company saw public cloud ARR growth of 11% year-over-year and narrowed its full-year revenue outlook to the high end of previous ranges while increasing its EPS guidance.
Term
Q3 2026
“In Q3, Teradata marked another quarter of progress against the goals we set at the start of the year, driving total ARR growth, improving profitability and delivering strong free cash flow. The increased pace of new product innovation and new AI service capabilities is driving positive interest from customers.”
For the nine months ended September 30, 2026, Sempra reported total revenues of $9,843 million and net income of $3,206 million, a significant increase from $1,588 million in the prior year. The results were impacted by a $214 million gain on sales and higher equity earnings, partially offset by $205 million in regulatory disallowances.
Sempra reported a significant increase in net income for the nine months ended September 30, 2026, reaching $3,206 million compared to $1,588 million in the prior year. This growth was driven by higher equity earnings and a gain on sales, despite a $205 million regulatory disallowance and increased interest expenses.
Simon Property Group reported Q3 2026 Real Estate FFO of $1.277 billion, or $3.37 per diluted share, representing a 4.7% increase year-over-year. The company increased its full-year 2026 Real Estate FFO guidance and raised its quarterly dividend following strong leasing momentum and shopper traffic growth.
Term
Q3 2026
“We delivered another quarter of excellent financial and operational results. Leasing momentum continued, rents and occupancy increased and shopper traffic growth accelerated for the third consecutive quarter, driving robust retailer sales growth across our portfolio. Today, we are once again increasing our full-year 2026 Real Estate FFO per share guidance and raising our quarterly dividend.”
Eli Simon, Chief Executive Officer, President and Chief Operating Officer
Figma General Counsel and Secretary Brendan Mulligan Sells $247K of Stock
Brendan Mulligan, General Counsel and Secretary, sold 11,599 shares of Figma, Inc. at $21.30 a share, worth $247K in total on Nov 3, 2026. Shares held after the trade: 555,656 (-2.0%).
Willdan Group Signs $285M M&A Deal with Mantis Intermediate Holdings, LLC
Willdan Group completed its acquisition of Mantis Innovation for approximately $285 million in cash. The transaction was funded through $250 million in new term loan borrowings and $35 million from an existing revolving credit facility.
Castle Biosciences reported net revenues of $102.9 million for the third quarter of 2026, up from $83.0 million in 2025. Despite the revenue growth, the company realized a net loss of $4.1 million for the quarter, primarily driven by increased operating expenses in selling, general, and administrative functions.
Akamai Technologies reported Q3 2026 revenue of $1.12 billion, up 6% year-over-year, driven by 34% growth in Cloud Infrastructure Services. The company issued bullish long-term guidance, projecting revenue growth to accelerate to 17-22% in 2027 and total revenue to exceed $7.0 billion in 2028.
Term
Q3 2026
“Akamai delivered solid third quarter results, driven by continued momentum across security and Cloud Infrastructure Services (CIS). We are especially excited by the exceptional progress in Cloud Infrastructure Services, with more than $14 billion worth of multi-year commitments signed so far this year.”
Dr. Tom Leighton, Akamai's Chief Executive Officer
“Given our CIS momentum, track record of execution and continued strong pipeline, we expect Akamai's overall revenue growth to accelerate to 17% to 22% year-over-year when adjusted for foreign exchange* in 2027. We expect further acceleration in 2028 with total revenue projected to exceed $7.0 billion.”
Dr. Tom Leighton, Akamai's Chief Executive Officer
Definitive Healthcare reported Q3 2026 revenue of $54.7 million, a 9% decrease year-over-year, while narrowing its net loss to $5.4 million. The company noted it will not provide forward guidance or host an earnings call due to a pending non-binding acquisition proposal from Advent International.
Term
Q3 2026
“Since joining Definitive, I’ve been focused on listening to our customers and our employees. What I’ve heard confirms my belief in the strength of our position in the market, and it has also shown me where we can execute better. This quarter’s results demonstrate the underlying health of the business and a solid foundation to build upon.”
For the nine months ended September 30, 2026, GRAIL reported total revenue of $123.0 million, a 19% increase year-over-year, primarily driven by screening revenue. The company recorded a net loss of $307.0 million, slightly improved from $309.2 million in the prior year, while maintaining a cash and marketable securities balance of approximately $788.7 million.
Maplebear Inc. (Instacart) reported a cash and cash equivalents balance of $830 million as of September 30, 2026, an increase from $637 million at the end of 2025. The filing highlights a proposed merger with DoorDash and notes that the company had 236,630,090 shares of common stock outstanding as of October 30, 2026.
Howard Hughes Holdings reported third quarter 2026 results, featuring the first full quarter of contributions from its Vantage insurance segment which added $315.8 million in net earned premiums. The company also announced a strategic shift for its real estate division, Howard Hughes Communities, toward an asset-light development and asset management platform through planned asset monetizations.
Paylocity reported first quarter fiscal 2027 total revenue of $451.7 million, representing 10.7% year-over-year growth. The company also highlighted the completion of its acquisition of Aidora Inc. and the repurchase of $152.5 million of its common stock during the quarter.
Term
Q1 2027
“Fiscal 27 is off to a strong start, with first quarter recurring & other revenue growth of 12.0% as we continue to see strong execution by our go-to-market teams, industry leading revenue retention, and product innovation that is bringing to market meaningful new AI-driven experiences and solutions that create differentiation and drive ARPU.”
Toby Williams, President and Chief Executive Officer
Airbnb, Inc. filed its Form 10-Q for the period ending September 30, 2026, identifying as a large accelerated filer. The report outlines a multi-year product roadmap and global expansion strategy, while highlighting risks related to macroeconomic conditions, foreign currency fluctuations, and the evolving regulatory environment for short-term rentals.
e.l.f. Beauty reported strong growth for the quarter ended September 30, 2026, with net sales increasing 51% year-over-year to $520.8 million. Net income rose significantly to $30.0 million compared to $3.0 million in the prior year period, driven by robust consumer demand and the integration of the rhode acquisition.
Pulse Biosciences reported a net loss of $66.3 million for the nine months ended September 30, 2026, compared to $55.3 million in the prior year period, driven by increased research and development expenses. The company significantly strengthened its balance sheet through an at-the-market offering program, raising $142.7 million and ending the period with $189.2 million in cash, cash equivalents, and marketable securities.
SoFi Technologies, Inc. reported 1,297,840,447 shares of common stock outstanding as of October 30, 2026. During the second quarter of 2026, the company expanded its platform through the acquisitions of Peach Finance, Inc. and Composer Securities LLC. The filing highlights a focus on navigating evolving regulatory environments, managing interest rate volatility, and continuing to grow its fee-based revenue and Loan Platform Business.
Sana Biotechnology reported third quarter 2026 financial results, highlighting a cash position of $121.7 million and a cash runway expected to last into mid-2027. The company is progressing toward initiating clinical trials for its type 1 diabetes candidate SC451 and its non-Hodgkin lymphoma candidate SG293, with data readouts anticipated in 2027.
“We continue to make meaningful progress toward initiating clinical studies of SC451 later this year and SG293 in 1Q 2027. We aim to share data from both of these programs in 2027 and anticipate both have the potential for relatively rapid proof of concept. In particular, SC451 in type 1 diabetes may provide a rapid signal, similar to what was seen with UP421, on whether the therapy can evade immune detection and function in patients.”
Steve Harr, Sana’s President and Chief Executive Officer
For the nine months ended September 30, 2026, Fidus Investment Corp reported total investment income of $136.9 million and net investment income of $64.5 million. Total net assets grew to $774.4 million, though net asset value per share slightly decreased to $19.47 from $19.55 at the end of 2025.
Kieran O’Kane, the Chief Commercial Officer of Biodesix, Inc., departed the company effective November 2, 2026. He will be eligible for separation benefits under his existing Executive Severance and Change in Control Agreement as a result of his qualifying termination.
Castle Biosciences reported Q3 2026 revenue of $102.9 million, a 24% increase year-over-year, driven by strong volume growth in its TissueCypher test. The company raised its full-year 2026 revenue guidance to a range of $385-395 million and reported a net loss of $4.1 million for the quarter.
Term
Q3 2026
“Our team delivered another strong quarter, reflecting consistent execution across our portfolio. TissueCypher was a key contributor to our top-line performance, delivering 47% year-over-year growth in test report volume compared to the third quarter of 2025.”
Derek Maetzold, president and chief executive officer of Castle Biosciences